Skip to main content
. 2021 Jun 15:gfab196. doi: 10.1093/ndt/gfab196

Table 4.

Predictors of 28-day mortality in those not admitted to hospital at first presentation (n = 355, events = 28) (presented as hazard ratios with 95% confidence intervals)

Characteristics Univariable P-value Multivariable P-value
Age (years) 1.06 (1.03–1.10) <0.001 1.05 (0.99–1.10) 0.08
Sex (male) 1.43 (0.66–3.09) 0.37
Race
 White/Caucasian Ref.
 Asian 3.04 (0.91–10.17) 0.07
 Black/African descent 1.10 (0.26–4.69) 0.90
 Other/unknown 1.32 (0.18–9.83) 0.78
Tobacco use
 Never Ref.
 Current 0.98 (0.13–7.64) 0.98
 Prior 2.58 (1.12–5.98) 0.027 2.51 (1.01–6.25) 0.05
 Unknown 0.52 (0.18–1.53) 0.24
CFS (AU) 1.64 (1.31–2.07) <0.001 1.41 (1.05–1.89) 0.02
X-ray abnormality (yes) 4.08 (0.37–45.04) 0.25
CT scan abnormality (yes)
BMI (kg/m2) 1.04 (0.98–1.10) 0.17
Diabetes (yes) 1.62 (0.77–3.41) 0.20
Hypertension (yes) 0.70 (0.28–1.73) 0.44
Lung disease (yes) 1.74 (0.66–4.59) 0.26
Active malignancy 2.50 (0.59–10.53) 0.21
Autoimmune disease 4.73 (1.64–13.65) 0.004 3.85 (0.74–19.97) 0.11
ARB use (yes) 1.75 (0.77–3.98) 0.18
ACEi use (yes) 1.02 (0.35–2.94) 0.97
Dialysis (versus transplant) 4.91 (0.67–36.15) 0.118
Days between two presentations 1.03 (0.97–1.09) 0.32
Disease characteristics
COVID-19-related symptoms
 Cough (yes) 1.58 (0.70–3.55) 0.27
 Fever (yes) 1.24 (0.58–2.68) 0.58
 Shortness of breath (yes) 3.26 (1.39–7.62) 0.006 3.23 (1.31–7.96) 0.01
 Headache (yes) 1.83 (0.62–5.40) 0.26
 Diarrhoea (yes) 1.25 (0.43–3.65) 0.68
 Nausea/vomiting (yes)
Vital signs
 Temperature (°C) 1.16 (0.77–1.74) 0.48
 Respiration rate (per min) 1.07 (0.96–1.19) 0.24
 O2 saturation (%) 0.87 (0.78–0.98) 0.017
 Pulse rate (bpm) 1.00 (0.96–1.03) 0.84
Laboratory test results
 Lymphocyte (×1000/µL) 1.00 (0.76–1.31) 0.99
 CRP (mg/L) 1.00 (0.99–1.01) 0.36

bpm, beats per minute; O2, oxygen.